Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.32 MB | Adobe PDF |
Advisor(s)
Abstract(s)
In extreme environments such as Antarctica, a diverse range of organisms, including
diatoms, serve as essential reservoirs of distinctive bioactive compounds with significant implications
in pharmaceutical, cosmeceutical, nutraceutical, and biotechnological fields. This is the case of the new
species Craspedostauros ineffabilis IMA082A and Craspedostauros zucchellii IMA088A Trentin, Moschin,
Lopes, Custódio and Moro (Bacillariophyta) that are here explored for the first time for possible
biotechnological applications. For this purpose, a bioprospection approach was applied by preparing
organic extracts (acetone and methanol) from freeze-dried biomass followed by the evaluation of
their in vitro antioxidant properties and inhibitory activities on enzymes related with Alzheimer’s
disease (acetylcholinesterase: AChE, butyrylcholinesterase: BChE), Type 2 diabetes mellitus (T2DM,
α–glucosidase, α–amylase), obesity (lipase) and hyperpigmentation (tyrosinase). Extracts were then
profiled by ultra-high-performance liquid chromatography–mass spectrometry (UPLC–HR–MS/MS),
while the fatty acid methyl ester (FAME) profiles were established by gas chromatography–mass
spectrometry (GC–MS). Our results highlighted strong copper chelating activity of the acetone extract
from C. ineffabilis and moderate to high inhibitory activities on AChE, BChE, α–amylase and lipase
for extracts from both species. The results of the chemical analysis indicated polyunsaturated fatty
acids (PUFA) and their derivatives as the possible compounds responsible for the observed activities.
The FAME profile showed saturated fatty acids (SFA) as the main group and methyl palmitoleate
(C16:1) as the predominant FAME in both species. Overall, our results suggest both Antarctic strains
as potential sources of interesting molecules with industrial applications. Further studies aiming to
investigate unidentified metabolites and to maximize growth yield and natural compound production
are required.
Description
Keywords
Antarctica Biological activity Antioxidant activity PUFAs Blue biotechnology Extreme environments
Citation
Marine Drugs 22 (1): 35 (2024)
Publisher
MDPI